• Explore /
  • Poster
  • / Effects of losartan and vitamin D on outcomes in metastatic pancreatic adenocarcinoma.

Effects of losartan and vitamin D on outcomes in metastatic pancreatic adenocarcinoma.

Abstract Poster

Authors

null

Adam Adika

Temple University Health System, Philadelphia, PA;

Adam Adika , Dina Ioffe , Meghan Connors , Emily C. Duboy , Kristen A. Sorice , Jill Hasler , Shannon M. Lynch , Edna Cukierman , Sanjay S. Reddy , Igor A. Astsaturov , Efrat Dotan

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 723)

DOI

10.1200/JCO.2023.41.4_suppl.723

Abstract #

723

Poster Bd #

L10

Abstract Disclosures

Similar Posters

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Clinical impact of <em>KRAS</em> mutations in metastatic pancreatic ductal adenocarcinoma (PDAC).

Clinical impact of KRAS mutations in metastatic pancreatic ductal adenocarcinoma (PDAC).

First Author: Carter Norton

First Author: George P. Kim

First Author: E. Gabriela Chiorean

First Author: Kohei Shitara